Individuals who have insulin-dependent diabetes mellitus (IDDM) are at a markedly increased risk of death [1] [2] [3] , the reasons for which are not known. The Diabetes Epidemiology Research International (DERI) Group has recently demonstrated a considerable variation across countries and the possible risk factors for the excess mortality in Japan and the United States in contrast to . These geographic differences highlight countries and societies such as Japan and the USA where mortality is excessive and could be reduced. Disappointingly, other than for these four countries, there are few other directly comparable data in the world. A primary reason being the expense of establishing large population-based registries with mortality follow-up.
Summary The aim of this study was to evaluate the geographic variation in mortality among individuals with youth-onset insulin-dependent diabetes mellitus (IDDM) across the world. The study was based on the currently available IDDM incidence and mortality data. Mortality data for diabetes in the 0-24 year age group were obtained from World Health Organization (WHO) statistics. The mortality rates were adjusted for the frequency of occurrence of IDDM by dividing the mortality rates by the IDDM incidence rates which were obtained from the WHO DiaMond project. There was a more than 10-fold geographic variation in mortality between the developed countries and Eastern European populations. The areas with the highest mortality rates were located in Japan, Eastern Europe and Russia. The areas having the best outcome associated with IDDM were Northern Europe, Central Europe, and Canada. An ecological study demonstrated a relationship between the incidence-adjusted mortality (estimated case-fatality) with IDDM incidence itself (Spearman's correlation coefficient = -0.45) as well as infant mortality and life expectancy at birth. These data demonstrated the possibility of an enormous geographic variation in mortality of youth-onset diabetic patients even in developed countries. It is important to note that these excess deaths are potentially preventable. The ecological study also suggested that the mortality differences may be in part related to overall and diabetes related care. [Diabetologia (1997) 40: 212-216] Keywords IDDM, mortality, incidence, epidemiology, life expectancy.
certificates which may often be unreliable and include exclusively the deaths from diabetic acute complications. It is essential to compare the degree of underestimation for diabetes mortality among countries. Another difficulty in employing diabetes mortality rates is that the primary determinant of the overall mortality rates is the number of people who have diabetes under age 25 years. Thus, countries with higher diabetes mortality rates, not unexpectedly, are those who have more cases of diabetes in this age group. This is particularly true for IDDM as there is an enormous (30-fold) international variation in the frequency of the disease [8] . Therefore, for meaningful comparisons to be made concerning cross-population differences in diabetes mortality, one has to control for differences in the number of patients who have diabetes. To accomplish this, we employed the incidence-adjusted mortality (mortality per incidence or case fatality). The aim of this study was to examine the degree to which there is a variation in incidence-adjusted IDDM mortality among countries.
Subjects and methods

Data source
Diabetes Epidemiology Research International (DERI) Mortality study. As the mortality statistics from WHO are based upon death certificates, we had to be cautious, since it is possible that death certificates for some IDDM patients may not include diabetes as a cause of death. If there are large differences across countries with regard to reporting diversity on the death certificate, then it is difficult to determine if apparent crosscountry differences are the result of nations varying in the inclusion of diabetes on the death certificate. We were able to examine this question in the DERI mortality study. The DERI mortality study is a follow-up of youth-onset IDDM patients in Finland, Israel, Japan and the United States. Detailed information about the DERI study has been described elsewhere [4, 5] . By reviewing the death certificates for people known to have IDDM in the DERI cohorts, we were able to determine if there was differential reporting on the death certificate across these countries. As will be demonstrated, having diabetes on the death certificates primarily represented diabetic acute-complication-related deaths, and there was a consistent degree of reporting across countries.
Incidence data. The current study used incidence data collected through the effort of WHO DiaMond project [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Each registry in the DiaMond project was conducted in a standardized manner. The criteria for IDDM are described as follows: 1) clinical diagnosis by a physician; 2) placed on daily insulin injections before 15th birthday; 3) resident in the area of registration at the time of the first insulin administration.
Mortality data. Mortality data for the 0-24 year age group in 1989 or 1990 were obtained from the WHO World Health Statistics Annual [7] . We assumed that it would be rare for NIDDM patients to die before 25 years of age. Therefore, the mortality in the 0-24 year age group would most likely demonstrate the mortality almost exclusively due to IDDM. We limited the populations to developed countries and Eastern Europe following the definition by WHO [7] .
Statistical analysis
The current study first evaluated the IDDM mortality rates for ages 0 to 24 years. Then mortality rates were assessed after adjustment for the frequency of IDDM in each country. The adjustment was performed by dividing the IDDM mortality rates from the WHO statistics by the incidence rates from DiaMond project.
Incidence -adjusted mortality = number of deaths from a disease number of diagnosed cases of that disease 100
(estimated case-fatality rate (%))
Both incidence rates and mortality rates were age-adjusted for world population [7] . The weighting used for each age category were 0.0466 for 0 year of age, 0.1845 for 1-4 years , 0.3972 for 5-14 years, and 0.3717 for 15-24 years.
The second component of this study was to relate socioeconomic indices to the IDDM mortality rates. The socioeconomic indices used in the analysis were gross national product (GNP) per capita, life expectancy at birth, infant mortality from the WHO's 12 global indicators to monitor and evaluate the strategy for health [7, [27] [28] [29] [30] [31] [32] . To examine and summarize the association between the variables, the Spearman's rank correlation coefficients on which extreme points had small effect were employed. All statistical procedures were conducted in SAS 6.08 [33] .
Results
Extrapolation from the DERI study. The percentage of all deaths before 25 years of age with the term "diabetes" on their death certificates as a cause of death in four countries, Finland, Israel, Japan, and the United States, which participated in the DERI mortality study, were 59 %, 25 %, 57 % and 64 %, respectively. Approximately 60 % (78/135) of total deceased patients in the cohorts had the term "diabetes" on their death certificates. Except for Israel, whose sample size was quite small (6 deaths before 25 years of age), the proportions of those with the term "diabetes", were quite similar among the cohorts. Therefore, it can be assumed that we could apply the data from death certificate to the comparison of early mortality among developed countries in the world, as at least in countries with a sufficient number of deaths there was little difference.
Causes of death between those with "diabetes" on a death certificate and those without were compared. Not unexpectedly, 80 % (37/46) of those who died of diabetic acute complications had "diabetes" on their death certificates. In contrast, only 29 % of those who died of traumatic events had "diabetes" on their death certificates. Thus, "diabetes" on the death certificate represented diabetic acute-complication-related deaths which were typically thought to be preventable.
Variation in mortality and case-fatality rates among countries. The variation of mortality is shown in Table 1. In addition, Table 1 exhibits the rate ratios for case fatality rates using Norway as the standard population. We selected Norway as a basis as it had a high incidence rate, and mortality was determined on a large number of patients. The second reason is that it had a lower case-fatality rate compared to most of the other countries. Table 1 demonstrates that there was enormous geographic variation in mortality ratios in IDDM across the world. Individuals with IDDM in Sofia, Bulgaria, were 10 times more likely to die than those in Norway prior to the age of 25 years.
The adjusted-mortality rates can be roughly grouped into the lowest, those having a mortality ratio up to twice that of Norway, medium, up to 4 times that of Norway, highest, up to 10 times that of Norway. As indicated earlier, these differential mortality rates represent primarily diabetic acute-complication-related deaths. The areas having the highest mortality ratios were located in Japan, Eastern Europe and Russia. The areas having the best outcome associated with IDDM were Northern Europe, Central Europe, and Canada.
Correlation between case fatality rate and socioeconomic indicators. Bivariate plotting of adjusted-mortality rates, and socioeconomic indicators and incidence rates are shown in Figure 1 . Infant mortality and life expectancy at birth were correlated with the case-fatality rate, indicating that the differences in diabetes deaths may be indicative of general population health. IDDM incidence itself was significantly correlated with the case-fatality rate where Spearman's rank correlation coefficient was -0.44 (p < 0.02). Thus, in areas where there are a large number of cases, mortality is low.
Discussion
International comparative studies offer an excellent method for identifying areas of high diabetic acutecomplication-related deaths; areas where preventive measures could be implemented. Up to now, however, only the DERI study has been available representing only four countries. By employing frequency adjusted diabetes mortality statistics we were able to extend the geographic comparisons for the four populations to 24 populations. The results demonstrated an almost 10-fold variation in the risk of dying across countries, with young Japanese and Eastern Europeans having by far the highest mortality. As the IDDM incidence rates were measured in the comparable way, they are considered reliable. The other measurement in the current study is the mortality rate. The results from the DERI mortality study suggest that there is a high congruence across countries concerning mortality of IDDM patients before 25 years of age with a similar proportion of patients being reported on death certificates. It is unlikely that a more than 10-fold difference in mortality risk could be attributed to differential completion of death certificates.
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DERI mortality study where by far the lowest mortality was in Finland followed by the United States whites, United States blacks and Japanese. Also, a 10-fold difference in morality rates is unlikely to be attributed to an artifact. However, we should discuss the assumptions and the limitations of the current ecological study. First, there is a concern that the WHO statistics do not separate IDDM and NIDDM. However, it can be assumed that the vast majority of diabetic deaths in the younger age group were exclusively due to IDDM since over 90 % of diabetic patients who develop diabetes under 20 years of age are IDDM [34] . Moreover, NIDDM in general does not have such a markedly increased mortality compared with IDDM. The other concern is that WHO mortality statistics are based on the information from death certificates. There are limitations in mortality statistics from death certificates; for example, in general, diabetes is not likely to be listed on the death certificate and thus is not considered a cause of death. However, if the populations are limited to developed countries and the deaths are limited to those before 25 years of age, the mortality data from death certificates may reflect the true values although they may be underestimated, if our experience of the DERI study can be extrapolated to other developed countries. Therefore, the variation in mortality found in this study may reflect the variation in case-fatality from deaths which are highly attributed to diabetes itself, in particular, diabetic acute complications under the assumptions described above.
It should be emphasized, again, that we dealt with the deaths exclusively from acute diabetic complications. The reason being that the deaths from chronic complications were in most part neglected since the deaths were limited to those before 25 years of age and based on death certificates. Similarly, other causes of deaths such as accident and suicide may not be considered. Therefore, we have difficulty in referring to the variation in mortality from chronic complications, accident and suicide by using the current data.
Considering these issues under assumptions, we concluded that there may be a considerable geographic variation in IDDM case-fatality across the world and hypothesized the cause-effect relationship between the low incidence rate and the high case-fatality rate. Over a 10-fold variation in IDDM case-fatality indicates that a large number of IDDM patients world-wide die unnecessarily.
Countries with the higher incidence of IDDM tended to have the lower mortality. This may reflect the greater expertise of the physicians in treating diabetic children, thus the better the outcome and the lower risk of dying. If a paediatrician, for example, in his/ her lifetime sees only one case in Japan, there is probably a very different pattern of care than for a paediatrician diagnosing 5-10 cases per year as in Finland. Moreover, the mortality statistics used in the study did not include the deaths in older age groups; therefore, the effect of poor medical care on the overall mortality from IDDM may be magnified when considering the mortality in older age groups.
In conclusion, the study based on WHO statistics evaluated the case-fatality rates in a number of regions in the world, and demonstrated the possibility of an enormous geographic variation in mortality of IDDM patients even among developed countries. Since the current study is ecological by using the mortality data derived from death certificates, the results should be interpreted with caution. However, we can at least make the hypothesis to prevent premature deaths among people with diabetes. This study also suggested that the mortality differences were in part related to overall and diabetes-related care. It is important to continue to monitor the mortality associated with IDDM worldwide as most of the deaths are probably preventable, and to complete the analytical approach to identify the risk factors for premature death among individuals with IDDM.
